Andreas Horner

497 total citations
22 papers, 287 citations indexed

About

Andreas Horner is a scholar working on Pulmonary and Respiratory Medicine, Oncology and Physiology. According to data from OpenAlex, Andreas Horner has authored 22 papers receiving a total of 287 indexed citations (citations by other indexed papers that have themselves been cited), including 22 papers in Pulmonary and Respiratory Medicine, 9 papers in Oncology and 5 papers in Physiology. Recurrent topics in Andreas Horner's work include Lung Cancer Treatments and Mutations (9 papers), Chronic Obstructive Pulmonary Disease (COPD) Research (8 papers) and Cancer Immunotherapy and Biomarkers (8 papers). Andreas Horner is often cited by papers focused on Lung Cancer Treatments and Mutations (9 papers), Chronic Obstructive Pulmonary Disease (COPD) Research (8 papers) and Cancer Immunotherapy and Biomarkers (8 papers). Andreas Horner collaborates with scholars based in Austria, Netherlands and United Kingdom. Andreas Horner's co-authors include Bernd Lamprecht, Bernhard Kaiser, David Lang, Kaveh Akbari, Franz A. Fellner, Klaus Langer, Sylvia Hartl, Gabriel Rinnerthaler, Monika Merkle and Florin Mihălţan and has published in prestigious journals such as SHILAP Revista de lepidopterología, Cancers and Lung Cancer.

In The Last Decade

Andreas Horner

20 papers receiving 283 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Andreas Horner Austria 10 223 78 74 27 26 22 287
Piero Candoli Italy 11 228 1.0× 47 0.6× 97 1.3× 14 0.5× 22 0.8× 19 300
June G. Eilers United States 5 238 1.1× 131 1.7× 49 0.7× 28 1.0× 9 0.3× 6 361
Quan Mai United States 7 141 0.6× 78 1.0× 32 0.4× 12 0.4× 19 0.7× 11 336
Cecilia Mouronte‐Roibás Spain 13 253 1.1× 63 0.8× 40 0.5× 19 0.7× 41 1.6× 21 344
Eric L. Flenaugh United States 9 179 0.8× 75 1.0× 36 0.5× 12 0.4× 28 1.1× 27 245
Kaveh Akbari Austria 7 361 1.6× 72 0.9× 118 1.6× 22 0.8× 47 1.8× 23 434
Olívia Meira Dias Brazil 12 177 0.8× 26 0.3× 104 1.4× 20 0.7× 49 1.9× 36 324
Kimberley L. Kiong Singapore 11 89 0.4× 143 1.8× 62 0.8× 18 0.7× 11 0.4× 27 337
Lisa Evans United States 9 75 0.3× 45 0.6× 24 0.3× 9 0.3× 82 3.2× 15 292

Countries citing papers authored by Andreas Horner

Since Specialization
Citations

This map shows the geographic impact of Andreas Horner's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Andreas Horner with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Andreas Horner more than expected).

Fields of papers citing papers by Andreas Horner

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Andreas Horner. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Andreas Horner. The network helps show where Andreas Horner may publish in the future.

Co-authorship network of co-authors of Andreas Horner

This figure shows the co-authorship network connecting the top 25 collaborators of Andreas Horner. A scholar is included among the top collaborators of Andreas Horner based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Andreas Horner. Andreas Horner is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Lang, David, et al.. (2024). Antibody–drug conjugates (ADCs) in lung cancer treatment. memo - Magazine of European Medical Oncology. 17(3). 198–203. 3 indexed citations
2.
Hochmair, Maximilian J., et al.. (2024). (Neo)adjuvant approaches in lung cancer—paving the road to a cure. memo - Magazine of European Medical Oncology. 17(1). 10–14.
3.
4.
Horner, Andreas, Horst Olschewski, Sylvia Hartl, et al.. (2023). Physical Activity, Depression and Quality of Life in COPD – Results from the CLARA II Study. International Journal of COPD. Volume 18. 2755–2767. 9 indexed citations
5.
6.
7.
Lang, David, Florian Huemer, Gabriel Rinnerthaler, et al.. (2021). Sex-Based Clinical Outcome in Advanced NSCLC Patients Undergoing PD-1/PD-L1 Inhibitor Therapy—A Retrospective Bi-Centric Cohort Study. Cancers. 14(1). 93–93. 10 indexed citations
8.
Lang, David, Andreas Horner, Kaveh Akbari, et al.. (2021). First-Line Pembrolizumab Mono- or Combination Therapy of Non-Small Cell Lung Cancer: Baseline Metabolic Biomarkers Predict Outcomes. Cancers. 13(23). 6096–6096. 17 indexed citations
9.
Lang, David, Kaveh Akbari, Andreas Horner, et al.. (2020). Serum Tumor Marker Dynamics as Predictive Biomarkers in NSCLC Chemo-Immunotherapy and Mono-Immunotherapy Maintenance: A Registry-Based Descriptive Study. SHILAP Revista de lepidopterología. 1 indexed citations
10.
Horner, Andreas, Otto C. Burghuber, Sylvia Hartl, et al.. (2020). <p>Quality of Life and Limitations in Daily Life of Stable COPD Outpatients in a Real-World Setting in Austria – Results from the CLARA Project</p>. International Journal of COPD. Volume 15. 1655–1663. 15 indexed citations
11.
12.
Lang, David, Kaveh Akbari, Andreas Horner, et al.. (2020). Standardized Computed Tomography Findings as Determinants of Local and Systemic Inflammation in Interstitial Lung Disease Patients. A3392–A3392. 1 indexed citations
13.
Lang, David, Kaveh Akbari, Andreas Horner, et al.. (2020). Computed tomography findings as determinants of pulmonary function tests in fibrotic interstitial lung diseases—Network-analyses and multivariate models. Chronic Respiratory Disease. 17. 405209457–405209457. 4 indexed citations
14.
Mihălţan, Florin, Yochai Adir, Adam Antczak, et al.. (2019). Importance of the relationship between symptoms and self-reported physical activity level in stable COPD based on the results from the SPACE study. Respiratory Research. 20(1). 89–89. 21 indexed citations
15.
16.
Lang, David, Florian Huemer, Gabriel Rinnerthaler, et al.. (2019). Therapy Line and Associated Predictors of Response to PD-1/PD-L1-Inhibitor Monotherapy in Advanced Non-small-Cell Lung Cancer: A Retrospective Bi-centric Cohort Study. Targeted Oncology. 14(6). 707–717. 12 indexed citations
17.
Breyer‐Kohansal, Robab, Marie‐Kathrin Breyer, Otto C. Burghuber, et al.. (2019). The prevalence of restrictive lung function in a general population obtained by spirometry and bodyplethysmography-Data from the LEAD study. PA358–PA358. 1 indexed citations
18.
Lang, David, et al.. (2018). Complications of CT-guided transthoracic lung biopsy. Wiener klinische Wochenschrift. 130(7-8). 288–292. 42 indexed citations
19.
Horner, Andreas, et al.. (2018). Adherence to inhaled therapy and its impact on chronic obstructive pulmonary disease (COPD). BMC Pulmonary Medicine. 18(1). 163–163. 71 indexed citations
20.
Horner, Andreas, Joan B. Soriano, Milo A. Puhan, et al.. (2017). Altitude and COPD prevalence: analysis of the PREPOCOL-PLATINO-BOLD-EPI-SCAN study. Respiratory Research. 18(1). 162–162. 26 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Piero Candoli Breakdown of academic impact, for papers by June G. Eilers Breakdown of academic impact, for papers by Quan Mai Breakdown of academic impact, for papers by Cecilia Mouronte‐Roibás Breakdown of academic impact, for papers by Eric L. Flenaugh Breakdown of academic impact, for papers by Kaveh Akbari Breakdown of academic impact, for papers by Olívia Meira Dias Breakdown of academic impact, for papers by Kimberley L. Kiong Breakdown of academic impact, for papers by Lisa Evans
Rankless by CCL
2026